CJC-1295 + Ipamorelin is a combination of two peptides often studied in research connected to growth-hormone-related signalling, pulsatile release and hormonal regulation models. The combination is interesting because the two peptides approach the same research field from different angles. In simple terms, CJC-1295 + Ipamorelin is used in research to study how growth-hormone-related signalling can be regulated in controlled models. This page describes the research field in accessible language, without medical advice or human-use instructions.
What it is
CJC-1295 is a modified peptide studied in connection with the GHRH system — the signalling pathway tied to growth-hormone release in research models. Ipamorelin is a different type of peptide studied within ghrelin- and GHSR-related signalling. Together, the combination makes it possible to investigate two distinct pathways within the same research area.
What it is studied for
CJC-1295 + Ipamorelin is mainly studied within endocrinology and hormone-related peptide research. Common research areas include growth-hormone-related signalling, pulsatile release in laboratory models, GHRH- and GHSR-related pathways, hormonal regulation, peptide combinations, stability and formulation, and comparisons with the individual peptides. The key takeaway is that the combination is often used in research that compares how two complementary peptides behave together versus separately.
What makes the combination different
What makes the combination especially interesting is that it pairs two peptides with different roles in the same overall signalling system. CJC-1295 is mainly tied to GHRH-related signalling, while Ipamorelin is tied to ghrelin-like signalling via GHSR. In the catalogue it differs from peptides such as Tirzepatide and Retatrutide, which sit within metabolic and incretin-related research. CJC-1295 + Ipamorelin belongs instead to research on hormonal regulation, pulsatile models and peptide combinations.
Storage and handling
CJC-1295 + Ipamorelin is supplied as a lyophilised powder — freeze-dried material — which keeps the formulation more stable prior to reconstitution. It should be protected from heat, strong light and repeated temperature changes. After reconstitution it should be handled according to established laboratory practice, with clean transfer equipment and limited exposure to light and temperature changes.
Documentation
Peptidverket provides batch documentation covering identity, purity and visual specification. Analytical methods such as HPLC and mass spectrometry are typically used to verify peptide material.
Related compounds
Compare with related research overviews: BPC-157, GHK-Cu. Companion lab supplies include bacteriostatic water & measurement syringes.
References and documentation
Each batch supplied through Peptidverket is documented with a certificate of analysis covering identity, purity and appearance. Researchers are encouraged to consult peer-reviewed primary literature for detailed pharmacological discussion and to validate analytical assays against their own controls.
Related product
View the corresponding research-grade formulation in the catalogue: CJC-1295 + Ipamorelin formulation →
This page is provided for general research context only. Material is supplied as a research-grade formulation for controlled laboratory environments. It is not a consumer product, is not formulated for human or veterinary use, and no therapeutic claims are made.